Sotera Health Co. (SHC)
19.51
+0.34
(+1.77%)
USD |
NASDAQ |
Aug 25, 16:00
19.51
0.00 (0.00%)
After-Hours: 19:59
Sotera Health Profit Margin (Quarterly) : 16.69% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.69% |
| March 31, 2026 | 9.49% |
| December 31, 2025 | 11.48% |
| September 30, 2025 | 15.55% |
| June 30, 2025 | 2.70% |
| March 31, 2025 | -5.21% |
| December 31, 2024 | 4.24% |
| September 30, 2024 | 5.95% |
| June 30, 2024 | 3.16% |
| March 31, 2024 | 2.54% |
| December 31, 2023 | 12.40% |
| September 30, 2023 | -5.19% |
| June 30, 2023 | 9.16% |
| March 31, 2023 | 1.28% |
| Date | Value |
|---|---|
| December 31, 2022 | -126.7% |
| September 30, 2022 | 10.00% |
| June 30, 2022 | 11.29% |
| March 31, 2022 | 12.80% |
| December 31, 2021 | 14.74% |
| September 30, 2021 | 11.98% |
| June 30, 2021 | 16.69% |
| March 31, 2021 | 5.22% |
| December 31, 2020 | -20.01% |
| September 30, 2020 | 0.31% |
| June 30, 2020 | 3.40% |
| March 31, 2020 | -1.06% |
| December 31, 2019 | -14.34% |
| September 30, 2019 | -2.84% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ginkgo Bioworks Holdings, Inc. | -284.4% |
| Natera, Inc. | -8.90% |
| Myriad Genetics, Inc. | -22.65% |
| Guardant Health, Inc. | -35.87% |
| Quest Diagnostics, Inc. | 10.94% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 27.65% |
| Return on Assets | 5.00% |
| Return on Invested Capital | 5.68% |
| Gross Profit Margin (Quarterly) | 54.44% |
| Operating Margin (Quarterly) | 37.98% |
| Return on Net Operating Assets | 5.85% |